Clinical Trials Browser

Phase 2 × Extensive Stage Lung Small Cell Carcinoma × Clear all

NCT04696575 2025-12-15

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Phase 2 Recruiting

Extensive Stage Lung Small Cell Carcinoma

NCT02899728 2023-10-17

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

Phase 2 Terminated

9 enrolled 4 charts

Extensive Stage Lung Small Cell Carcinoma